Logo image of OB

OUTBRAIN INC (OB) Stock Fundamental Analysis

NASDAQ:OB - Nasdaq - US69002R1032 - Common Stock - Currency: USD

6.07  -0.47 (-7.19%)

After market: 6.09 +0.02 (+0.33%)

Fundamental Rating

4

Taking everything into account, OB scores 4 out of 10 in our fundamental rating. OB was compared to 71 industry peers in the Interactive Media & Services industry. OB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

OB had positive earnings in the past year.
In the past year OB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: OB reported negative net income in multiple years.
OB had a positive operating cash flow in each of the past 5 years.
OB Yearly Net Income VS EBIT VS OCF VS FCFOB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

OB's Return On Assets of 0.66% is fine compared to the rest of the industry. OB outperforms 62.12% of its industry peers.
With a decent Return On Equity value of 1.55%, OB is doing good in the industry, outperforming 65.15% of the companies in the same industry.
Industry RankSector Rank
ROA 0.66%
ROE 1.55%
ROIC N/A
ROA(3y)-0.08%
ROA(5y)-1.4%
ROE(3y)-0.81%
ROE(5y)-5.7%
ROIC(3y)N/A
ROIC(5y)N/A
OB Yearly ROA, ROE, ROICOB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

OB's Profit Margin of 0.39% is in line compared to the rest of the industry. OB outperforms 57.58% of its industry peers.
OB's Profit Margin has improved in the last couple of years.
The Gross Margin of OB (20.95%) is worse than 84.85% of its industry peers.
In the last couple of years the Gross Margin of OB has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 0.39%
GM 20.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y70.29%
PM growth 5YN/A
GM growth 3Y-2.83%
GM growth 5YN/A
OB Yearly Profit, Operating, Gross MarginsOB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 5 10 15 20

More info and screens

6

2. Health

2.1 Basic Checks

OB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OB has less shares outstanding
The debt/assets ratio for OB has been reduced compared to a year ago.
OB Yearly Shares OutstandingOB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
OB Yearly Total Debt VS Total AssetsOB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.53 indicates that OB is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of OB (2.53) is better than 68.18% of its industry peers.
There is no outstanding debt for OB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.53
ROIC/WACCN/A
WACC8.25%
OB Yearly LT Debt VS Equity VS FCFOB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 1.20 indicates that OB should not have too much problems paying its short term obligations.
OB has a Current ratio of 1.20. This is in the lower half of the industry: OB underperforms 71.21% of its industry peers.
OB has a Quick Ratio of 1.20. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
OB has a worse Quick ratio (1.20) than 71.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
OB Yearly Current Assets VS Current LiabilitesOB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

OB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 120.00%, which is quite impressive.
Measured over the past years, OB shows a very strong growth in Earnings Per Share. The EPS has been growing by 81.64% on average per year.
Looking at the last year, OB shows a decrease in Revenue. The Revenue has decreased by -4.45% in the last year.
The Revenue has been growing slightly by 6.85% on average over the past years.
EPS 1Y (TTM)120%
EPS 3Y81.64%
EPS 5YN/A
EPS Q2Q%1000%
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y6.85%
Revenue growth 5YN/A
Sales Q2Q%-2.54%

3.2 Future

The Earnings Per Share is expected to grow by 61.81% on average over the next years. This is a very strong growth
OB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.56% yearly.
EPS Next Y191.96%
EPS Next 2Y200.56%
EPS Next 3Y128.32%
EPS Next 5Y61.81%
Revenue Next Year-3.71%
Revenue Next 2Y8.66%
Revenue Next 3Y9.44%
Revenue Next 5Y5.56%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
OB Yearly Revenue VS EstimatesOB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
OB Yearly EPS VS EstimatesOB Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 101.17 indicates a quite expensive valuation of OB.
OB's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 29.63. OB is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 12.33 indicates a correct valuation of OB.
80.30% of the companies in the same industry are more expensive than OB, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, OB is valued a bit cheaper.
Industry RankSector Rank
PE 101.17
Fwd PE 12.33
OB Price Earnings VS Forward Price EarningsOB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OB is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, OB is valued a bit cheaper than the industry average as 71.21% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.38
EV/EBITDA 40.79
OB Per share dataOB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OB's earnings are expected to grow with 128.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y200.56%
EPS Next 3Y128.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTBRAIN INC

NASDAQ:OB (2/21/2025, 8:00:01 PM)

After market: 6.09 +0.02 (+0.33%)

6.07

-0.47 (-7.19%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-27 2025-02-27/amc
Inst Owners49.19%
Inst Owner Change26.7%
Ins Owners23.01%
Ins Owner Change-0.24%
Market Cap566.94M
Analysts80
Price Target7.47 (23.06%)
Short Float %1.18%
Short Ratio1.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.33%
Min EPS beat(2)35.81%
Max EPS beat(2)284.85%
EPS beat(4)4
Avg EPS beat(4)87.85%
Min EPS beat(4)6.99%
Max EPS beat(4)284.85%
EPS beat(8)6
Avg EPS beat(8)509.34%
EPS beat(12)8
Avg EPS beat(12)323.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.89%
Min Revenue beat(2)-9.09%
Max Revenue beat(2)-4.69%
Revenue beat(4)0
Avg Revenue beat(4)-5.66%
Min Revenue beat(4)-9.09%
Max Revenue beat(4)-4.18%
Revenue beat(8)1
Avg Revenue beat(8)-4.63%
Revenue beat(12)3
Avg Revenue beat(12)-2.58%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.33%
PT rev (3m)22.08%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)-31.11%
EPS NY rev (1m)-34.21%
EPS NY rev (3m)177.78%
Revenue NQ rev (1m)-4.44%
Revenue NQ rev (3m)-5.53%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-1.7%
Valuation
Industry RankSector Rank
PE 101.17
Fwd PE 12.33
P/S 0.63
P/FCF 16.38
P/OCF 11.04
P/B 2.5
P/tB 3.88
EV/EBITDA 40.79
EPS(TTM)0.06
EY0.99%
EPS(NY)0.49
Fwd EY8.11%
FCF(TTM)0.37
FCFY6.1%
OCF(TTM)0.55
OCFY9.06%
SpS9.67
BVpS2.43
TBVpS1.57
PEG (NY)0.53
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.66%
ROE 1.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.39%
GM 20.95%
FCFM 3.83%
ROA(3y)-0.08%
ROA(5y)-1.4%
ROE(3y)-0.81%
ROE(5y)-5.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y70.29%
PM growth 5YN/A
GM growth 3Y-2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 86.25%
Cap/Sales 1.86%
Interest Coverage N/A
Cash Conversion 515.13%
Profit Quality 985.2%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 2.53
F-Score8
WACC8.25%
ROIC/WACCN/A
Cap/Depr(3y)99.03%
Cap/Depr(5y)83.17%
Cap/Sales(3y)2.25%
Cap/Sales(5y)1.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)120%
EPS 3Y81.64%
EPS 5YN/A
EPS Q2Q%1000%
EPS Next Y191.96%
EPS Next 2Y200.56%
EPS Next 3Y128.32%
EPS Next 5Y61.81%
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y6.85%
Revenue growth 5YN/A
Sales Q2Q%-2.54%
Revenue Next Year-3.71%
Revenue Next 2Y8.66%
Revenue Next 3Y9.44%
Revenue Next 5Y5.56%
EBIT growth 1Y47.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year614.48%
EBIT Next 3Y120.3%
EBIT Next 5Y76.32%
FCF growth 1Y174.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y392.06%
OCF growth 3Y-36.22%
OCF growth 5YN/A